Cargando…
The pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses
We are proposing the use of pulmonary-proteoliposome as a new therapeutic approach for Coronaviruses. The designed strategy represents a potential treatment to reduce the overall viral load in the lungs and to help the immune system to successfully stave off the infection.
Autores principales: | Feliciello, Isidoro, Procino, Alfredo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232879/ https://www.ncbi.nlm.nih.gov/pubmed/32401611 http://dx.doi.org/10.1080/21645515.2020.1758534 |
Ejemplares similares
-
Reverse transcription-quantitative PCR (RT-qPCR) without the need for prior removal of DNA
por: Đermić, Damir, et al.
Publicado: (2023) -
Anti-Tumor Effects of Bak-Proteoliposomes against Glioblastoma
por: Liguori, Lavinia, et al.
Publicado: (2015) -
Oriented Insertion of ESR-Containing Hybrid Proteins in Proteoliposomes
por: Petrovskaya, Lada E., et al.
Publicado: (2023) -
Structural Investigation of the Transmembrane Domain
of KCNE1 in Proteoliposomes
por: Sahu, Indra D., et al.
Publicado: (2014) -
Regulation of ssb Gene Expression in Escherichia coli
por: Feliciello, Isidoro, et al.
Publicado: (2022)